Loading…
Held by equity mutual funds in 10 disclosed months, Dec 2025 to Sep 2026.
Corona Remedies Limited (Pharmaceuticals & Biotechnology) was held by 25 active equity mutual funds in September 2026, ₹1,838 Cr in all (up 7 funds from Aug 2026). The largest position was Invesco India Pharma and Healthcare Fund at 6.1% of its portfolio. During the month 7 funds entered and 0 exited. Funds have disclosed holding it since Dec 2025.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.
None.
None.